AxoGen, Inc.
AXGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.33 | 0.52 | -2.36 | -1.72 |
| FCF Yield | 0.00% | -7.05% | -8.89% | -10.83% |
| EV / EBITDA | 126.75 | -24.84 | -20.12 | -20.15 |
| Quality | ||||
| ROIC | -1.88% | -12.78% | -17.18% | -13.56% |
| Gross Margin | 75.79% | 80.42% | 82.58% | 81.99% |
| Cash Conversion Ratio | -0.46 | 0.26 | 0.55 | 0.50 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.57% | 7.68% | 7.26% | 6.07% |
| Free Cash Flow Growth | 100.05% | 44.71% | 10.73% | -29.74% |
| Safety | ||||
| Net Debt / EBITDA | 6.77 | -2.87 | -2.22 | -1.66 |
| Interest Coverage | -0.40 | -7.57 | -47.61 | -18.74 |
| Efficiency | ||||
| Inventory Turnover | 1.37 | 1.35 | 1.28 | 1.37 |
| Cash Conversion Cycle | 249.54 | 189.55 | 208.70 | 223.47 |